710 related articles for article (PubMed ID: 16874413)
1. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
Sato M
Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
[TBL] [Abstract][Full Text] [Related]
2. Wnt/β-catenin pathway forms a negative feedback loop during TGF-β1 induced human normal skin fibroblast-to-myofibroblast transition.
Liu J; Wang Y; Pan Q; Su Y; Zhang Z; Han J; Zhu X; Tang C; Hu D
J Dermatol Sci; 2012 Jan; 65(1):38-49. PubMed ID: 22041457
[TBL] [Abstract][Full Text] [Related]
3. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts.
Wang Z; Gao Z; Shi Y; Sun Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhu X; Wu H; Jin Y
J Plast Reconstr Aesthet Surg; 2007; 60(11):1193-9. PubMed ID: 17889631
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation.
Sun Q; Guo S; Wang CC; Sun X; Wang D; Xu N; Jin SF; Li KZ
Int J Clin Exp Pathol; 2015; 8(6):7631-9. PubMed ID: 26261683
[TBL] [Abstract][Full Text] [Related]
6. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids.
Lee TY; Chin GS; Kim WJ; Chau D; Gittes GK; Longaker MT
Ann Plast Surg; 1999 Aug; 43(2):179-84. PubMed ID: 10454326
[TBL] [Abstract][Full Text] [Related]
7. Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.
Phan TT; Lim IJ; Aalami O; Lorget F; Khoo A; Tan EK; Mukhopadhyay A; Longaker MT
J Pathol; 2005 Oct; 207(2):232-42. PubMed ID: 16052471
[TBL] [Abstract][Full Text] [Related]
8. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics.
Polo M; Smith PD; Kim YJ; Wang X; Ko F; Robson MC
Ann Plast Surg; 1999 Aug; 43(2):185-90. PubMed ID: 10454327
[TBL] [Abstract][Full Text] [Related]
9. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW
Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582
[TBL] [Abstract][Full Text] [Related]
10. Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions.
Tsujita-Kyutoku M; Uehara N; Matsuoka Y; Kyutoku S; Ogawa Y; Tsubura A
In Vivo; 2005; 19(6):959-63. PubMed ID: 16277007
[TBL] [Abstract][Full Text] [Related]
11. Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1.
Xie JL; Qi SH; Pan S; Xu YB; Li TZ; Liu XS; Liu P
Dermatol Surg; 2008 Sep; 34(9):1216-24; discussion 1224-5. PubMed ID: 18616749
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of TGF-β1 in keloids and hypertrophic scars.
Abdou AG; Maraee AH; Al-Bara AM; Diab WM
Am J Dermatopathol; 2011 Feb; 33(1):84-91. PubMed ID: 20559120
[TBL] [Abstract][Full Text] [Related]
13. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management.
Slemp AE; Kirschner RE
Curr Opin Pediatr; 2006 Aug; 18(4):396-402. PubMed ID: 16914994
[TBL] [Abstract][Full Text] [Related]
14. Role of Smad3, acting independently of transforming growth factor-beta, in the early induction of Wnt-beta-catenin signaling by parathyroid hormone in mouse osteoblastic cells.
Inoue Y; Canaff L; Hendy GN; Hisa I; Sugimoto T; Chihara K; Kaji H
J Cell Biochem; 2009 Sep; 108(1):285-94. PubMed ID: 19582775
[TBL] [Abstract][Full Text] [Related]
15. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts.
Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J
Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513
[TBL] [Abstract][Full Text] [Related]
16. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
[TBL] [Abstract][Full Text] [Related]
17. A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts.
Chu Y; Guo F; Li Y; Li X; Zhou T; Guo Y
Connect Tissue Res; 2008; 49(2):92-8. PubMed ID: 18382895
[TBL] [Abstract][Full Text] [Related]
18. The molecular basis of keloid and hypertrophic scar formation.
Tuan TL; Nichter LS
Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin/LEF-1 signalling in breast cancer--central players activated by a plethora of inputs.
Gebeshuber CA; Sladecek S; Grunert S
Cells Tissues Organs; 2007; 185(1-3):51-60. PubMed ID: 17587808
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study of actin and myosin in the scar tissue].
Zhang Q; Qian YL; Cui L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):32-5. PubMed ID: 12563927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]